Altre lingue Talphera, Inc.

Azioni

TLPH

US00444T2096

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
1,04 ^USD	+2,97%		-8,77%	+41,50%

06/03	Talphera, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
06/03	Transcript : Talphera, Inc., Q4 2023 Earnings Call, Mar 06, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Talphera: Q4 Earnings Snapshot	06/03
Talphera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members	04/03
Talphera, Inc. Announces Management Changes	01/03
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members	01/03
Talphera, Inc. Appoints Abhinav Jain to Serve as a Class II Director	22/01
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA Acquisition	19/01
XOMA Acquires Interest in Pain Management Medication Dsuvia for $8 Million	18/01
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering	18/01
XOMA Corporation acquired DSUVIA® of Talphera, Inc. for $8 million.	18/01
Talphera, Inc. announced that it expects to receive $16 million in funding from Nantahala Capital Management, LLC, Rosalind Advisors, Inc.	17/01
AcelRx Pharmaceuticals, Inc. will Change its Ticker to TLPH from ACRX	10/01
AcelRx Announces Rebranding With Name Change to Talphera, Inc.	09/01
Talphera Expects to Initiate the Registrational Study of Niyad	09/01
Talphera, Inc.(NasdaqGM:TLPH) dropped from NASDAQ Composite Index	09/01
AcelRx Pharmaceuticals, Inc. has Changed its Name to Talphera, Inc	09/01
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States	12/12
AcelRx Pharmaceuticals: Q3 Earnings Snapshot	08/11
AcelRx Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2023	08/11

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Talphera, Inc.

Azioni

TLPH

US00444T2096

Altre lingue

Filtri